JBIO · Jade Biosciences, Inc. · Documents
$14.59
-0.32 (-2.15%)
At close · Oct 23
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“If we are unable to raise additional capital when needed, that could raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 10, 2026
Market Cap
$927.89M
Shares
63.60M
Volume · Oct 23
634.38K
Avg daily vol (3M)
903.02K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2026-09-30 | — | |
| Investor Event Transcript | — | 2026-09-14 | 2026-09-30 | |
| Investor Event Transcript | — | 2026-09-08 | 2026-09-30 | |
| 10-Q | — | 2026-08-10 | 2026-06-30 | |
| 8-K | — | 2026-08-10 | — | |
| 8-K | — | 2026-07-01 | 2026-06-29 | |
| 8-K | — | 2026-06-26 | 2026-06-25 | |
| 8-K | — | 2026-06-11 | 2026-06-08 | |
| DEFA14A | — | 2026-06-05 | — | |
| 8-K | — | 2026-06-04 | 2026-06-03 | |
| 8-K | — | 2026-06-01 | — | |
| S-3 | — | 2026-05-07 | — | |
| 8-K | — | 2026-05-07 | — | |
| S-3 | — | 2026-05-07 | — | |
| 10-Q | — | 2026-05-07 | 2026-03-31 | |
| ARS | — | 2026-04-28 | 2025-12-31 | |
| DEF 14A | — | 2026-04-28 | 2026-06-09 | |
| DEFA14A | — | 2026-04-28 | — | |
| 8-K | — | 2026-04-22 | 2026-04-18 | |
| Investor Event Transcript | — | 2026-04-21 | 2026-06-30 | |
| PRE 14A | — | 2026-04-17 | 2026-06-09 | |
| 8-K | — | 2026-04-02 | 2026-03-31 | |
| 8-K | — | 2026-03-06 | — | |
| 10-K | — | 2026-03-06 | 2025-12-31 | |
| 8-K | — | 2026-01-05 | — | |
| S-1 | — | 2025-12-22 | — | |
| 8-K | — | 2025-12-15 | 2025-12-13 | |
| S-1 | — | 2025-11-14 | — | |
| 8-K | — | 2025-11-14 | 2025-11-13 | |
| 10-Q | — | 2025-11-14 | 2025-09-30 | |
| 8-K | — | 2025-10-07 | 2025-10-03 | |
| 8-K | — | 2025-09-09 | 2025-09-05 | |
| 8-K | — | 2025-08-13 | — | |
| 10-Q | — | 2025-08-13 | 2025-06-30 | |
| 8-K | — | 2025-07-01 | 2025-06-25 | |
| 8-K | — | 2025-05-14 | — | |
| 8-K | — | 2025-05-01 | 2025-04-28 | |
| 8-K | — | 2025-04-29 | — | |
| 10-Q | — | 2025-04-25 | 2025-03-31 | |
| 8-K | — | 2025-04-23 | — | |
| 8-K | — | 2025-04-21 | 2025-04-16 | |
| 8-K | — | 2025-04-09 | — | |
| 8-K | — | 2025-04-09 | — | |
| 8-K | — | 2025-04-07 | — | |
| 10-K | — | 2025-03-27 | 2024-12-31 | |
| ARS | — | 2025-03-25 | 2024-12-31 | |
| S-4/A | — | 2025-03-24 | — | |
| S-4/A | — | 2025-03-14 | — | |
| S-4/A | — | 2025-02-24 | — | |
| S-4/A | — | 2025-01-22 | — |
Showing 1–50 of 113 filings
Key facts
CIK
1798749
CUSIP
008064206
13F (30d)
13 filings
13 filers
Visit website
Investor relations